Pharma companies spent almost $3M on marketing in Vermont for FY 2008
Pharma Compliance Alert, April 22, 2009
Pharmaceutical manufacturers paid almost $3 million to 2,280 doctors, hospitals, universities, and others to market their drugs in fiscal year 2008, according to the Vermont Attorney General’s (AG) sixth annual Report on Pharmaceutical Marketing Disclosures.
Almost half of the reported marketing expenditures were for speaking fees and payments, while nearly 25% was for marketing. Almost 60% of the expenditures were direct payments to recipients in the form of cash or check.
Read more about pharmaceutical marketing disclosures in Vermont.
- Study: Almost half of nurses are thinking about leaving the profession
- Fracture coding in ICD-10-CM requires greater specificity
- Differentiate between types of wound debridement
- What does case-mix index mean to you?
- Complications from immobility by body system
- OB services: Coding inside and outside of the package
- Pneumonia with a negative chest x-ray: Clinical diagnoses, physician documentation, and coding guidelines
- Don’t forget the three checks in medication administration
- Note similarities and differences between HCPCS, CPT® codes
- What is the difference between an IPA and a medical group?
- Bill and charge for supplies correctly to reduce risk and minimize lost revenue
- Seven tips for slashing ED wait times with limited resources
- Increase patient satisfaction by improving your discharge process
- Homecare Direction
- QA:Coding multiple initial infusions
- Q&A: Coding for transplant complications
- Peeling away the confusion: Split billing guidance
- OIG focuses on documentation, frequency, and duration for outpatient PT services
- Note from the Instructor: Review of hospital inpatient mental health services payable under the inpatient psychiatric facility prospective payment system (IPF PPS)
- HIPAA Q&A: Maintenance of medical records after physician death